Parallax Volatility Advisers, L.P. Acadia Pharmaceuticals Inc Call Options Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $53,400 - $76,950	3,000 Added 11.11%	30,000 $718,000
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $440,640 - $564,840	27,000 New	27,000 $508,000
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $418,800 - $550,000	-20,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $335,800 - $541,800	20,000 New	20,000 $467,000
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $16,170 - $27,380	-1,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $14,320 - $22,920	1,000 New	1,000 $16,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.